Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00186680 · ClinicalTrials.gov registry record · Phase 1
CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant
A Phase 1 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 1
- Development phase
- 99
- Enrollment target
NCT00186680: Completed Phase 1 study, sponsored by Stanford University.
NCT00186680 is a Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 99 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (65% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00186680, a Phase 1 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 99 participants
- Enrollment target
Study Summary
Evaluate the feasibility and safety of autologous transplantation of CD34+Thy-1+ hematopoietic stem cells afer high dose marrow ablative chemotherapy in patients with breast cancer.
Interventions
- PROCEDURE high dose chemo then auto hematopoietic cell transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 1996-09 |
| Est. Completion | 2005-06 |
| Phase | Phase 1 |
What the finished NCT00186680 record still lists
NCT00186680 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (65% higher).
The record links to 0 conditions, and to 1 intervention - of which high dose chemo then auto hematopoietic cell transplant is the first listed.
NCT00186680 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00186680 about?
NCT00186680 is a clinical study titled "CD34 Selection of the Peripheral Blood Stem Cell Graft for Autologous Transplant". Evaluate the feasibility and safety of autologous transplantation of CD34+Thy-1+ hematopoietic stem cells afer high dose marrow ablative chemotherapy in patients with breast cancer.
What is the current status of trial NCT00186680?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 99 participants. The study started on 1996-09. Estimated completion is 2005-06.
What interventions are being tested in trial NCT00186680?
The interventions under investigation include: high dose chemo then auto hematopoietic cell transplant (PROCEDURE).
Who is sponsoring clinical trial NCT00186680?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00186680's enrollment target sits among peer trials
99 590th of 2000 higher than 1,409 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia